FI974442A0 - Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia - Google Patents

Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia

Info

Publication number
FI974442A0
FI974442A0 FI974442A FI974442A FI974442A0 FI 974442 A0 FI974442 A0 FI 974442A0 FI 974442 A FI974442 A FI 974442A FI 974442 A FI974442 A FI 974442A FI 974442 A0 FI974442 A0 FI 974442A0
Authority
FI
Finland
Prior art keywords
pct
catechol
date
derivatives useful
pde
Prior art date
Application number
FI974442A
Other languages
English (en)
Swedish (sv)
Other versions
FI974442A (fi
FI114468B (fi
Inventor
Allen J Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI974442A0 publication Critical patent/FI974442A0/fi
Publication of FI974442A publication Critical patent/FI974442A/fi
Application granted granted Critical
Publication of FI114468B publication Critical patent/FI114468B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Pyridine Compounds (AREA)
FI974442A 1995-06-07 1997-12-05 Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia FI114468B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/007208 WO1996040636A1 (en) 1995-06-07 1995-06-07 Catechol diethers derivatives useful as pharmaceutical agents
US9507208 1995-06-07

Publications (3)

Publication Number Publication Date
FI974442A0 true FI974442A0 (fi) 1997-12-05
FI974442A FI974442A (fi) 1997-12-05
FI114468B FI114468B (fi) 2004-10-29

Family

ID=22249266

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974442A FI114468B (fi) 1995-06-07 1997-12-05 Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia

Country Status (11)

Country Link
US (1) US6028086A (fi)
EP (1) EP0869945B1 (fi)
JP (1) JP3410104B2 (fi)
AT (1) ATE237589T1 (fi)
CA (1) CA2223245C (fi)
DE (1) DE69530429T2 (fi)
DK (1) DK0869945T3 (fi)
ES (1) ES2193196T3 (fi)
FI (1) FI114468B (fi)
PT (1) PT869945E (fi)
WO (1) WO1996040636A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9903919D0 (en) * 1999-02-19 1999-04-14 Darwin Discovery Ltd Aminophenols and their therapeutic use
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
CA2402384A1 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
WO2002102778A1 (fr) * 2001-06-15 2002-12-27 Yamanouchi Pharmaceutical Co., Ltd. Derive de phenylpyridinecarbonylpiperazine
CA2504820C (en) 2002-11-06 2011-08-23 Grelan Pharmaceutical Co., Ltd. Pyrazolonaphthyridine derivatives
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
CN101268073B (zh) 2005-09-15 2011-10-19 Aska制药株式会社 杂环化合物、制备方法及其用途
US8604031B2 (en) * 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
GB9315595D0 (en) * 1993-07-28 1993-09-08 Res Inst Medicine Chem New compounds

Also Published As

Publication number Publication date
DE69530429T2 (de) 2003-10-30
ATE237589T1 (de) 2003-05-15
DE69530429D1 (de) 2003-05-22
CA2223245C (en) 2002-05-21
PT869945E (pt) 2003-09-30
JP2001527508A (ja) 2001-12-25
EP0869945B1 (en) 2003-04-16
DK0869945T3 (da) 2003-07-14
JP3410104B2 (ja) 2003-05-26
ES2193196T3 (es) 2003-11-01
FI974442A (fi) 1997-12-05
FI114468B (fi) 2004-10-29
MX9709869A (es) 1998-03-31
WO1996040636A1 (en) 1996-12-19
CA2223245A1 (en) 1996-12-19
US6028086A (en) 2000-02-22
EP0869945A1 (en) 1998-10-14

Similar Documents

Publication Publication Date Title
NO971811L (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
CA2166721A1 (en) Bicyclic tetrahydro pyrazolopyridines
DK0738270T3 (da) Dihydropyrazolopyrroler
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
WO2004094388A3 (en) Indazole derivatives as jnk inhibitors
AP2002002589A0 (en) Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes.
NO980313L (no) N-(aroyl)glysin-hydroksaminsyre-derivater og beslektete forbindelser
FI945555A0 (fi) Substituoituja oksindoleja
BG103195A (en) Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf)
DE60107820D1 (de) Neue verwendung von phenylheteroalkylamin-derivaten
YU69902A (sh) Novi derivati piperazina
FI974442A (fi) Farmaseuttisina aineina hyödyllisiä katekolidieetterijohdannaisia
CA2258285A1 (en) Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
CA2252982A1 (en) Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
HUP0402422A2 (hu) Deuterizált szubsztituált pirazolil-benzolszulfonamid-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
ATE327225T1 (de) Neue verwendung von benzothiazolderivaten
BG108426A (en) Novel sulfonic acid derivatives
MY116527A (en) Tricyclic 5, 6-dihydro-9h-pyrazolo [3,4,-c]-1,2,4- triazolo [4,3-a] pyridines
WO1999018099B1 (en) Aryl thiophene derivatives as pde iv inhibitors
CO5660084A1 (es) Nuevos derivados de fenilheteroalquilamina, proceso para su prepraracion, composiciones farmaceuticas que comprenden dichos derivados novedosos y su uso en terapia

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114468

Country of ref document: FI

MA Patent expired